deferoxamine has been researched along with naloxone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bianchine, JR; Couri, D | 1 |
| Donovan, DL; Fink, JA; Pigott, JP; Sharp, WV | 1 |
| Meredith, TJ; Vale, JA | 1 |
| Proudfoot, AT | 1 |
| Dart, RC; Fulton, B; Koziol-McLain, J; Lowenstein, SR; Stark, Y | 1 |
| Bowden, CA; Krenzelok, EP | 1 |
| King, WD; Teresi, WM | 1 |
4 review(s) available for deferoxamine and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antidotal therapy: pharmacokinetic aspects.
Topics: Administration, Oral; Antidotes; Deferoxamine; Dimercaprol; Hot Temperature; Humans; Injections, Intramuscular; Kinetics; Naloxone; Penicillamine; Physical Exertion; Poisoning; Pralidoxime Compounds; Thiamine | 1986 |
Antidotes: benefits and risks.
Topics: Acetylcysteine; Animals; Antidotes; Deferoxamine; Flumazenil; Humans; Naloxone | 1995 |
Clinical applications of commonly used contemporary antidotes. A US perspective.
Topics: Acetylcysteine; Antidotes; Antivenins; Atropine; Deferoxamine; Flumazenil; Humans; Hydroxocobalamin; Naloxone; Physostigmine; Poisoning; Succimer | 1997 |
5 other study(ies) available for deferoxamine and naloxone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Management of the drug overdose patient. Part II. Specific antidotes.
Topics: Antidotes; Cholinesterase Inhibitors; Deferoxamine; Humans; Iron; Methanol; Naloxone; Poisoning; Pralidoxime Compounds | 1977 |
Experimental pharmacologic cerebroprotection.
Topics: Allopurinol; Animals; Arachidonic Acid; Arachidonic Acids; Brain; Deferoxamine; Ischemic Attack, Transient; Male; Naloxone; Rats; Rats, Inbred Strains; Superoxide Dismutase | 1988 |
Insufficient stocking of poisoning antidotes in hospital pharmacies.
Topics: Analysis of Variance; Antidotes; Antivenins; Colorado; Deferoxamine; Emergency Medical Services; Ethanol; Immunoglobulin Fab Fragments; Montana; Naloxone; Nevada; Pharmacy Service, Hospital; Pralidoxime Compounds; Regression Analysis | 1996 |
Survey of the stocking of poison antidotes in Alabama hospitals.
Topics: Alabama; Antidotes; Antivenins; Cyanides; Deferoxamine; Equipment and Supplies; Ethanol; Fomepizole; Humans; Immunoglobulin Fab Fragments; Naloxone; Pharmacy Service, Hospital; Pralidoxime Compounds; Pyrazoles; Pyridoxine; Regression Analysis | 1999 |